Many lines of evidence indicate that GABA and GABA A receptors make important contributions to human sleep regulation. Pharmacological manipulation of these receptors has differential effects on sleep onset and sleep maintenance insomnia. Here we show that sleep is regulated by GABA in Drosophila and that a mutant GABA A receptor, Rdl A302S , specifically decreases sleep latency. The drug carbamazepine (CBZ) has the opposite effect on sleep; it increases sleep latency as well as decreasing sleep. Behavioral and physiological experiments indicated that Rdl A302S mutant flies are resistant to the effects of CBZ on sleep latency and that mutant RDL A302S channels are resistant to the effects of CBZ on desensitization, respectively. These results suggest that this biophysical property of the channel, specifically channel desensitization, underlies the regulation of sleep latency in flies. These experiments uncouple the regulation of sleep latency from that of sleep duration and suggest that the kinetics of GABA A receptor signaling dictate sleep latency.
Many lines of evidence indicate that GABA and GABA A receptors make important contributions to human sleep regulation. Pharmacological manipulation of these receptors has differential effects on sleep onset and sleep maintenance insomnia. Here we show that sleep is regulated by GABA in Drosophila and that a mutant GABA A receptor, Rdl A302S , specifically decreases sleep latency. The drug carbamazepine (CBZ) has the opposite effect on sleep; it increases sleep latency as well as decreasing sleep. Behavioral and physiological experiments indicated that Rdl A302S mutant flies are resistant to the effects of CBZ on sleep latency and that mutant RDL A302S channels are resistant to the effects of CBZ on desensitization, respectively. These results suggest that this biophysical property of the channel, specifically channel desensitization, underlies the regulation of sleep latency in flies. These experiments uncouple the regulation of sleep latency from that of sleep duration and suggest that the kinetics of GABA A receptor signaling dictate sleep latency.
Insomnia is the most common sleep problem and affects approximately one third of the adult American population 1 . Patients with insomnia are generally subdivided into three categories: sleep onset insomnia, sleep maintenance insomnia and terminal insomnia (earlymorning awakening coupled with an inability to return to sleep) 2 . The biological basis for these insomnia classifications remains unknown. Nonetheless, a single class of drugs, agonistic modulators of GABA A receptors, effectively ameliorates these diverse symptoms 2, 3 . GABA A receptors are a family of pentameric ligand-gated Cl -channels 4 and are a major source of inhibitory currents throughout the CNS 5, 6 . These receptors are also an important target for pharmacologic treatment of many other neurological disorders in addition to sleep 7 .
The fruit fly Drosophila melanogaster is an ideal model for dissecting the relationships between molecules and behaviors, as well as between different sleep states 8, 9 . As in mammals, it has been shown that the sleep-like state of Drosophila is associated with reduced sensory responsiveness and reduced brain activity 10, 11 , and is subject to both circadian and homeostatic regulation 12, 13 . Researchers have also identified a number of genes 14, 15 , circuits 16, 17 and biological processes 18 that affect fly sleep. However, there is no reported role for GABA and no reported manipulation of GABA receptors in fly sleep studies.
The first GABA A receptor mutant was isolated from pesticideresistant Drosophila and the locus was named Resistant to dieldrin (Rdl) 19, 20 . Similar to mammalian GABA A receptors, RDL channels mediate fast inhibitory neurotransmission 21 and are expressed in the CNS 22 . Notably, the mutation that causes the insecticide resistance phenotype (A302S) 20 specifically decreases the rate of RDL desensitization with little or no effect on other channel properties 23 . As a consequence, the mutant receptor has a longer single channel open duration and, therefore, increased channel current, at least under certain conditions (see below). Because of these characteristics, and because this mutation does not have obvious effects on health or viability, we decided to establish the importance of GABAergic transmission to sleep in flies and to examine the effects of the Rdl mutation.
Interestingly, flies with this mutant GABA A receptor subunit slept more, primarily because of decreased sleep latency. CBZ, which accelerates RDL desensitization, had the opposite effect and increased sleep latency. Behavioral and electrophysiological experiments indicated that the Rdl mutant was largely resistant to the effects of CBZ, both its ability to alter desensitization and to decrease sleep latency. These results suggest that these two phenomena are mechanistically linked. To account for these observations, we propose that sleep is initiated by fast-firing GABAergic neurons.
RESULTS
To determine whether GABAergic transmission is important for sleep in Drosophila, we first used the GAL4/UAS system 24 to decrease GABA release by expressing the hyperpolarizing potassium channel Shaw 25 in GABAergic neurons. Total sleep was reduced, due in turn to an increase in mean wake-episode duration and to a decrease in sleep-bout duration. There was also an increase in the night-time sleep latency, consistent with a role for GABAergic tone in regulating both the initiation and maintenance of sleep (Fig. 1) .
To investigate the potential role of Rdl, the sleep pattern of an extensively outcrossed homozygous Rdl A302S strain, Rdl MDRR (see Methods), was assayed under standard light-dark (12-h:12-h lightdark cycles) conditions (Fig. 2) . As GABA A currents in Rdl A302S fly neurons have longer single channel open durations 23 , we surmised that these flies might have increased sleep, as a result of either decreased sleep latency and/or increased sleep duration. Indeed, Rdl MDRR flies had decreased sleep latency (compare the beginning of dark period in the control and Rdl MDRR genotypes in Fig. 2a ; see Fig. 2c , left for quantification). They also had a small, but significant, increase in total daily (24 h) sleep (P o 0.005; Fig. 2b, left) .
Despite the extensive outcrossing of the Rdl MDRR A302S mutant chromosome, we made two additional chromosome combinations to validate these results. We assayed an Rdl MDRR /Rdl 1 combination, which creates a hemizygous Rdl A302S allele because of the Rdl 1 null mutation 26 . We also assayed an independent homozygous Rdl A302S combination, made by crossing our outcrossed Rdl MDRR chromosome with an independent Rdl A302S mutant chromosome, Rdl CB1 . The latter was previously identified in another ethyl methanesulfonate screen on a different background chromosome. Both of the new combinations had a very similar sleep latency phenotype (Fig. 2c, middle and right) , and the Rdl A302S /Rdl 1 combination had little effect on total sleep duration (Fig. 2b, right) . None of these genotypes had substantial increases in locomotor activity during active periods, indicating that these sleep phenotypes are not the result of simple hyperactivity (data not shown). We conclude that the most consistent effect of the Rdl A302S mutation is to decrease sleep latency. In a search for a complementary approach to better understand the effect of the Rdl A302S mutation, we first assayed the sleep effects of a number of drugs on wild-type flies. Only the human anticonvulsant CBZ had a marked dose-dependent effect, with the highest dose (1.2 mg ml -1 ) almost completely inhibiting night-time sleep (Fig. 3a,b) . This was the result of both an increase in sleep latency (Fig. 3c) and a decrease in sleep-episode duration (Fig. 3d) . The number of sleep episodes appeared to show a biphasic response, with an increase at a low dose and a prominent, significant decrease at a high dose (P o 0.05; Fig. 3e ). Locomotor activity during active periods was unchanged (Fig. 3f) , indicating that the sleep effects were not the result of hyperactivity.
To relate these CBZ effects to the Rdl A302S phenotypes described above, we assayed the sleep of the homozygous Rdl A302S strain after CBZ feeding (Fig. 4) . The drug effects were less potent than in wildtype flies ( Fig. 4a,b ; also compare Fig. 4a with Fig. 3a) . This was because the sleep latency of Rdl A302S flies was almost completely resistant to CBZ; wild-type flies showed a large dose-dependent increase in sleep latency, whereas Rdl A302S latency remained unaffected, even at high levels of the drug (Fig. 4c) . This suggests that the latency effects of CBZ and the Rdl A302S mutation share a common mechanism. In contrast, the mutant flies were equally sensitive to the sleep-duration effects of the drug (Fig. 4d) . These data pharmacologically uncouple sleep latency from sleep duration.
The experiments also shed light on the mechanisms underlying sleep homeostasis. A decrease in sleep-episode duration with CBZ should normally increase sleep pressure, resulting in a compensatory increase in sleep-episode number. The CBZ-dependent block of sleep initiation, as well as sleep duration, in wild-type flies apparently affected this compensation by preventing an increase in the number of sleep episodes (Fig. 5a ). In contrast, Rdl A302S flies were able to increase the number of sleep episodes and, therefore, compensate for the decreased sleep duration, presumably because their ability to fall asleep was less affected by the drug (Fig. 5a ). This was also apparent in the marked difference in short 5-15 min sleep episodes between genotypes; only Rdl A302S flies were able to initiate more short episodes despite increasing drug concentrations (Fig. 5b,c) . These data further support the idea that sleep latency and duration are separable processes in flies and suggest that the Rdl GABA A receptor is the target responsible for the sleep latency effects of CBZ. To assay whether CBZ might directly affect the RDL channel, we expressed RDL in Xenopus oocytes and measured current in the presence of increasing concentrations of CBZ. CBZ specifically increased RDL desensitization without affecting peak amplitude after a single GABA pulse (Fig. 6a,b) . However, an increase in desensitization might alter the peak current amplitude of GABA pulse trains if they were sufficiently frequent to prevent channel recovery before the next pulse. Indeed, CBZ had a peak amplitude effect with this kind of GABA pulse-train stimulation protocol (Fig. 6c) . We concluded that the GABA application frequency determines the effect of CBZ on current amplitude. Importantly, the CBZ effect on RDL desensitization was completely blocked by the A302S mutation, which has a potent effect on desensitization without drug (ref. 23 and Fig. 6d ).
These data imply that the ability of the Rdl channel to desensitize is critical for sleep onset and provide a coherent, biophysical explanation for the drug's, as well as the mutant's, effects on sleep latency. Because desensitization is expected to have more significant effects on total current at synapses receiving high frequency input (Fig. 6) , we propose a model ( Supplementary Fig. 1 online) in which fast-firing GABAergic (sleep initiation) neurons induce sleep onset by inhibiting wakepromoting neurons. The desensitization-induced synaptic current reduction at sleep initiation-wake promoting synapses is enhanced by CBZ, which leads to a faster current decrease and increased sleep latency. The A302S mutant channel shows reduced desensitization, as well as reduced CBZ-sensitivity, consistent with the observed in vivo effects in these flies. The lack of a differential (A302S versus wild type) CBZ effect on sleep duration suggests that other, slower-firing GABAergic inputs maintain sleep (sleep maintenance neurons) and that the CBZ effects on sleep duration may also involve effects on other sleeprelevant molecules. 
DISCUSSION
Here we show that GABA and GABA A receptors are important for sleep in Drosophila. To the best of our knowledge, this is the first demonstration in an animal model that sleep onset and maintenance are differentially regulated by GABA A receptors, as well as by a pharmacological agent. The ability of Rdl mutant flies to mount a homeostatic response to the sleep-depriving drug CBZ further suggests that the sleep-regulating neurons that express this receptor are part of the core sleep circuit. These findings further support the use of Drosophila melanogaster as a model for understanding the mechanisms and function of mammalian sleep.
Our results suggest that GABAergic inputs control both the onset and maintenance of sleep, as both latency and duration of sleep episodes were affected by suppressing GABAergic transmission. Our finding that fast-desensitizing GABA A receptors preferentially controlled sleep initiation suggests that there are fast-spiking GABAergic sleep-initiation neurons that synapse onto RDL-expressing postsynaptic wake-promoting neurons (Supplementary Fig. 1 ). In this model, RDL channel desensitization should decrease wake-promoting hyperpolarization. The virtue of desensitization in this context is that it helps prevent spurious and/or unwanted sleep episodes. Sleep drive must be sufficient for sleep-initiation firing to occur for a sufficiently long time to achieve wake-promoting silencing. Only under conditions that sustain high-frequency sleep-initiation neuron firing does the animal fall asleep. Once wake-promoting neurons are quiescent, putative sleepmaintenance neurons are released from inhibition and act to maintain wake-promoting neurons below their action potential threshold. Other GABA receptor subunits (and/or other transmitter systems) are presumably more important than RDL for sleep-maintenance neurons. At the end of the night, extrinsic inputs, regulated by circadian as well as by homeostatic factors, presumably inhibit the sleep-promoting regions (sleep maintenance and sleep initiation) and the fly wakes up.
The latency assay, the time it takes flies to fall asleep once the lights have turned off at Zeitgeber Time 12, presumably reflects sleep pressure, which influences sleep-initiation neuronal firing. The importance of desensitization to sleep latency (or sleep initiation) is emphasized by the Rdl A302S phenotype, the kinetics of RDL A302S currents, the effect of CBZ on fly sleep and the effect of CBZ on wild-type and mutant receptor physiology. The slow decay kinetics of RDL A302S currents suggest that hyperpolarization of wake-promoting neurons occurs more easily in mutant flies. The stronger and more consistent mutant effect on sleep latency, as compared to sleep duration, indicates that the output of the sleep-initiation neurons is affected more strongly by the mutant receptor than that of sleep-maintenance neurons. Although this could reflect the presence of other GABA receptor subunits in sleep-maintenance neurons, it could also just reflect a slower firing rate. CBZ acts specifically on RDL desensitization and this effect is blocked by the RDL A302S mutation, which explains why the drug effect on sleep latency is substantially reduced in the Rdl A302S genotype.
There was an additional, prominent CBZ effect on sleep-episode duration, which was not ameliorated by the Rdl A302S mutation. This suggests that there are additional CBZ targets, which affect wakepromoting activity either directly or indirectly ( Supplementary Fig. 1 ). The multiple effects of CBZ on the Drosophila sleep circuit are not surprising, as its pharmacology in humans 27 indicates that it interacts with many targets, including sodium channels, GABA A receptors 28 and adenosine receptors.
Nonetheless, the decrease in fly sleep is the result, in part, of the unexpected CBZ effects on fly GABA A receptor kinetics. CBZ is widely used in the treatment of multiple neurological disorders, including epilepsy, bipolar disorder and trigeminal neuralgia 29 , and therapeutic drugs for these disorders might be expected to increase sleep. Indeed, several studies have reported that patients and healthy volunteers receiving CBZ therapy experience sleep problems, which normally disappear with long-term treatment 30 . It is intriguing that the CBZ effects on fly sleep also decrease with chronic drug treatment (data not shown). Our observations, along with others, further illustrate the potential utility of using Drosophila models combined with pharmacological approaches to better understand complex behaviors and disease states.
The similarities between fly and mammalian sleep suggest that altering subtle aspects of GABA A receptor function in mammals will also lead to discrete effects on sleep structure. Indeed, a human mutation altering desensitization and deactivation of a GABA A receptor subunit causes a familial type of insomnia 31 . Taken together with our data on the Drosophila RDL channel, this suggests that targeting specific aspects of GABA A receptor function such as desensitization will give rise to more specific and effective sleep therapeutics.
METHODS
Animals. Fly cultures were kept at 25 1C with a 12-h light/dark cycle on cornmeal, yeast, sucrose and agar food. The original Rdl A302S allele, Rdl MDRR , which was isolated from the wild 20 , and Rdl 1 /TM3 26 flies were obtained from the Bloomington Stock Center (Bloomington). Rdl CB1 was isolated in a modified dominant F1 screen for insecticide resistance in which Canton-S flies were ethyl methanesulfonate mutagenized using previously described methods 32 . For all strains, the third chromosome was crossed into Canton-S background; for Rdl MDRR the strain was subsequently outcrossed over six generations and isolated using PCR-ren 33 .
Behavioral assays and drug administration. Behavioral assays and analysis were carried out as previously described 12 . For all genotypes, the locomotor activity of 5-7-day-old flies loaded with 5% sucrose in 2% agar was monitored using the Trikinetics system (Waltham) in 24-h light-dark cycles. Data were collected in 1-min bins and a sliding window was applied. Sleep was defined as 5 consecutive min of inactivity 12, 34 ; sleep latency was measured from the time of lights off to the onset of the first sleep episode. For episodes flanking a given period, quantifications for sleep duration were done with episodes truncated to start and end in the respective periods. Only data from female flies are shown 34 . In all cases where we assayed male flies, we observed qualitatively similar results on sleep latency.
For experiments involving CBZ, a stock solution (20 mg ml -1 ) was solubilized in 45% (2-hydroxypropyl)-b-cyclodextrin (Sigma) and mixed into the standard agar medium. Experiments were carried out by recording 5-6 baseline d on standard medium, and then switching to CBZ/sucrose/agar 6 h before the onset of the dark period.
Electrophysiological recording. The wild-type Drosophila Rdl clone (GH019619) was obtained from the Drosophila Genome Collection 1 (DGC1). This clone lacks TM4 and has more stable desensitization kinetics (J.C.C. and J.A., unpublished results). Oocyte collection, injection and electrophysiological recordings were carried out as described 35, 36 . Two electrode voltage-clamp experiments were performed 1-5 d post-injection. An oocyte chamber of B200 ml was perfused with a flow rate of B10-15 ml min -1 and recording were made at a holding potential of -60 mV in Barth's solution (2 mM KCl, 5 mM HEPES, pH 7.6, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 100 mM NaCl). CBZ was dissolved in 45% (2-hydroxypropyl)-b-cyclodextrin (Sigma). Because cyclodextrin forms a complex with these drugs 37, 38 , the effective concentration of these agents is expected to be much lower that what is indicated in the experiments. We used GABA concentrations that were close to the saturated region of the dose-response curve because we observed that CBZ effects were essentially independent of GABA and that desensitization is more prominent in this range.
Statistical Analysis. Data were analyzed as described in the figure legends using JMP software version 5.0.1.2 for the PC and Macintosh (SAS Institute).
